Mahoney Michael F
- SEC CIK
- 0001533022
In the past year, 1 open-market purchase filing worth $9.00M and 1 sale filing worth $15.0M.
Current role at each company
- BSX Boston Scientific CorpChairman, President & CEOas of Aug 5, 2026
- CVS CVS Health CorpDirectoras of May 15, 2026
- BAX Baxter International IncDirectoras of May 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $9.00M
- 1 filing
- Sold
- $15.0M
- 1 filing
- Net
- −$6.04M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mahoney Michael F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BSX Boston Scientific Corp
Chairman, President & CEO20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)4:15 PM ET | Aug 3 | 2 days | Mahoney Michael FChairman, President & CEO | PPurchase | +186.2K | $48.33 | +$9.00M | +13.3%1.59M after | |
| Feb 3, 2026 (view filing) | Feb 2 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −160.9K | $93.49 | −$15.0M | −10.2%1.41M after | 2 lots10b5-1 |
| Jun 3, 2025 (view filing) | Jun 2 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −164.4K | $103.69 | −$17.1M | −10.0%1.48M after | 2 lots10b5-1 |
| May 5, 2025 (view filing) | May 1 | 4 days | Mahoney Michael FChairman, President & CEO | SSale | −164.4K | $102.48 | −$16.9M | −9.7%1.54M after | 2 lots10b5-1 |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −164.4K | $100.01 | −$16.4M | −9.3%1.59M after | 10b5-1 |
| Nov 7, 2024 (view filing) | Nov 5 | 2 days | Mahoney Michael FChairman, President & CEO | SSale | −162.8K | $84.75 | −$13.8M | −9.7%1.52M after | 2 lots10b5-1 |
| Oct 8, 2024 (view filing) | Oct 7 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −162.8K | $84.63 | −$13.8M | −9.4%1.57M after | 2 lots10b5-1 |
| Sep 6, 2024 (view filing) | Sep 5 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −162.8K | $81.17 | −$13.2M | −9.1%1.62M after | 10b5-1 |
| Nov 7, 2023 (view filing) | Nov 6 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −113.4K | $52.51 | −$5.95M | −7.0%1.50M after | |
| Oct 10, 2023 (view filing) | Oct 9 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −113.4K | $52.09 | −$5.90M | −7.0%1.50M after |
CVS CVS Health Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Mahoney Michael FDirector | PPurchaseCommon Stock (By Trust) | +30.0K | $66.70 | +$2.00M | +320.6%39.4K after | |
| May 2, 2024 (view filing) | May 2 | Same day | Mahoney Michael FDirector | PPurchaseCommon Stock (By Trust) | +9.18K | $54.49 | +$500.3K | +5,246.3%9.36K after |